Share
|
Copy Link
https://eyewire.news/tv/eyewiretv-january-6th-2021
https://eyewire.news/tv/oyster-point-submits-nda-for-investigational-nasal-spray-for-signs-and-symptoms-of-dry-eye-disease
https://eyewire.news/tv/ocular-therapeutix-submits-supplemental-nda-for-dextenza-for-ocular-itching-associated-with-allergic-conjunctivitis
https://eyewire.news/tv/eyenovia-submits-nda-for-fixed-combination-mydriatic-agent-mydcombi
https://eyewire.news/tv/genentech-announces-results-from-two-phase-3-studies-evaluating-faricimab-for-dme